Support The Moscow Times!

Reckitt Benckiser Posts Strong Results on Emerging Market Performance

British consumer goods group Reckitt Benckiser said it expected to post annual revenue growth at the top end of forecasts after a strong emerging markets performance and demand for its brands such as Dettol and Strepsils helped it to post first half sales up 6 percent.

To boost growth Reckitt is putting greater focus on its fastest growing health and hygiene brands like Dettol, Strepsils and Durex, and is moving quicker into the key emerging markets of Brazil, Russia, India and China.

The maker of Nurofen painkillers and Cillit Bang cleaners also on Monday said it remained bullish on demand for its heroin addiction drug Suboxone, despite competition from cheaper versions in tablet form.

First half sales rose 6 percent on a constant exchange rate to 5 billion pounds ($7.69 billion).

… we have a small favor to ask.

As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just 2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Continue

Read more